1. Schaider, H.,*
Oka ,* M., Bogenrieder, T., Nesbit, M.,
Satyamoorthy, K., Berking, C., Matsushima,
K., and Herlyn, M. Differential response
of primary and metastatic melanomas to neutrophils
attracted by IL-8. Int. J. Cancer 103: 335-43,
2003.* Equal contribution. PDF
version available
2. Gruss, C.J., Satyamoorthy, K., Berking,
C., Lininger, J., Nesbit, M., Schaider,
H., Liu, Z-J., Oka, M., Hsu, M-Y., Shirakawa,
T., Li, G., Bogenrieder, T., Carmeliet,
P., El-Deiry, W.S., Eck, S.L., Rao, J.S.,
Baker, A.H., Bennett, J.T., Crombleholme,
T.M., Velazquez, O., Karmacharya, J., Margolis,
D.J., Wilson, J.M., Detmar, M., Skobe, M.,
Robbins, P.D., Buck, C., and Herlyn, M.
Stroma formation and angiogenesis by induced
expression of growth factors, cytokines,
and proteolytic enzymes in human skin grafted
to SCID mice. J. Invest. Derm. 120: 683-692,
2003. PDF
version available
3. Meier, F., Caroli, U., Satyamoorthy,
K., Schittek, B., Bauer, J., Berking, C.,
Möller, H., Maczey, E., Rassner, G.,
Herlyn, M., and Garbe, C. Basic fibroblast
growth factor but not Mel-CAM and/or 3 integrin
promotes progression of melanocytes to melanoma.
Exp. Dermatol. 12: 296-306, 2003.
PDF version
available
4. Velazquez, O., and Herlyn, M. The vascular
phenotype of melanoma metastasis. Clin.
Exp. Met. 20: 229-235, 2003. (R). PDF
version available
5. Li, G., Meier, F., Berking, C., Satyamoorthy,
K., Bogenrieder, T., and Herlyn, M. Function
and regulation of melanoma-stromal fibroblast
interactions: when seeds meet soil. Oncogene
22: 3162-3171, 2003. PDF
version available
6. Zhang, H., Satyamoorthy, K., Herlyn,
M., and Rosdahl, I. All-trans retinoic acid
differentially induces apoptosis in primary
and metastatic melanoma cells. Carcinogenesis
24: 185-191, 2003. PDf
version available
7. Liu, Z-J., Shirakawa, T., Li, Y., Souma,
A., Fairman, R., Velazquez, O.C., and Herlyn,
M. Regulation of notch1 and dll4 by vascular
endothelial growth factor in arterial endothelial
cells: implications for modulating arteriogenesis
and angiogenesis. Mol. Cell Biol. 23: 14-25,
2003. PDF
version available
8. Satyamoorthy, K., and Herlyn, M. p16INK4A
and familial melanoma. Methods Mol. Biol.
222: 185-195, 2003.
9. Andl, C., Nakagawa,
H., Mizushima, T., Oyama, K., Harada, H.,
Chruma, Herlyn, M., and Rustgi, A.K. Epidermal
growth factor receptor mediates increased
cell proliferation, migration and aggregation
in esophageal keratinocytes in vitro and
in vivo. J. Biol. Chem. 278: 1824-1830,
2003. PDF
version available
10. Satyamoorthy, K.,* Li, G.,* Gerrero,
M.R., Brose, M.R., Volpe, P., Weber, B.L.,
Van Belle, P.A., Elder, D.E., and Herlyn,
M. Constitutive mitogen-activated protein
kinase activation in melanoma by both BRAF
mutations and autocrine growth factor stimulation.
Cancer Res. 63: 756-759, 2003. Equal contribution. PDF
version available
11. Marinocola, F.M., Wang, E., Herlyn,
M., Seliger, B., and Ferrone S. Tumors as
elusive targets for immunotherapy. Trends
Immunol., 23 : 334-341, 2003 . PDF
version available
12. Kalabis, J., Patterson, M.J., Gimotty,
P., Enders, G.H., Marian, B., Iozzo, R.V.,
Rogler, G., and Herlyn, M. Stimulation of
human colonic epithelial cells by leukemia
inhibitory factor is dependent on collagen-embedded
fibroblasts in organotypic culture. FASEB
J., Published on-line April 8, 2003 . PDF
version available
13. Li, G., Kalabis, J.,
Xu, X., Meier, F., Oka , M., Bogenrieder,
T., Herlyn, M. Reciprocal regulation of
MelCAM and AKT in melanoma. Oncogene 22:
6891-6899, 2003. PDF
version available
14. Cook, LA, Donatien, PD, Smith AG, Murphy,
M,Jones, M, Herlyn, M, Bennet, DC, Leonard,
JH, Sturm, RA: Human melanoblasts in culture:
Expression of Brn-2/POU3F2 and synergistic
regulation of FGF2, SCF and ET3. J. Invest.
Dermatol., 121: 1150-1159, 2003. PDF
version available
15. Liu, Z.J., Souma, A., Snyder, R., Fairman,
R.M., Herlyn, M., and Velazquez, O. ß3
intergin-mediated vascular network formation
is VEGF induced and involves the RAS and
PI3 kinase signalling pathways. FASEB J.
17: 1931-1933, 2003. PDF
version available
16. Bogenrieder, T, Elder,
D.E., Herlyn, M. Molecular and cellular
biology. In: Cutaneous Melanoma, 4th edition,
C. Balch, ed., Quality Medical Publ., St
Louis, MO, pp. 713-751, 2003 (R).
17. Bogenrieder, T. and Herlyn, M.: Axis
of evil: Molecular mechanisms of cancer
metastasis. Oncogene 42: 6524-6536, 2003
(R). PDF
version available
18. Song, J.H., Song, D.K., Herlyn, M.,
Petruk, K.C., and Hao, C: Cisplatin down-regulation
of cellular Fas-associated death domain-like
interleukin-1ß-converting enzyme-like
inhibitory proteins to restore tumor necrosis
factor-related apoptosis-inducing ligand-induced
apoptosis in human melanoma cells. Clin.
Cancer Res. 9: 4255-4266, 2003. PDF
version available
19. Tuveson, D. A., Weber, B.L., and Herlyn,
M.: BRAF as a potential therapeutic target
in melanoma and other malignancies. Cancer
Cell 4:95-8, 2003 (R). PDF
version available
20. Liu, Z-J and Herlyn, M.: Slit-Robo: Neuronal guides signal tumor angiogenesis. Cancer Cell 4: 1-2, 2003 (R). PDF version available
21. Hingorani, S.R., Jacobetz,
M.A., Robertson, G., Herlyn, M., Tuveson,
D.: Suppression of BRAFv599e
in human melanoma abrogates transformation.
Cancer Res. 63: 5198-5202, 2003. PDF
version available
22. Hirst, C.J., Herlyn, M., Cattini, P.A.,
Kardami, E: High levels of CUG-initiated
FGF-2 expression cause chromatincompaction,
decreased cardiomyocyte mitosis, and cell
death. Mol Cell Biochem. 246: 111-116, 2003.
PDF
version available
24. Smalley, K.S., and Herlyn, M. The great escape: Another way for melanoma to leave physiological control? J. Invest. Dermatol. 121: ix, 2003 (R). PDF version available
24. Herlyn, M., and Guerry, D IV. Meeting Report: First International Melanoma Research Congress. Cancer Biol. Therapy: 2:721-724, 2003. (R) PDF version available